Showing results (151-160 of 179) with videos related to
Sort By:
Pageof 18
Gene Therapy|July 26, 2002
Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomasA G Zeimet, E Müller-Holzner, A Schuler, et al.Anticancer Research|February 24, 2001
Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90KA G Zeimet, S Stadlmann, C Natoli, et al.Cancer Research|November 1, 1990
Gamma-interferon reduces expression of the protooncogene c-erbB-2 in human ovarian carcinoma cellsC Marth, E Müller-Holzner, E Greiter, et al.The American Journal of Pathology|December 14, 1999
Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1M V Cronauer, S Stadlmann, H Klocker, et al.Blood|August 15, 1996
Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancerB Eibl, H Schwaighofer, D Nachbaur, et al.International Journal of Cancer|September 17, 1996
Different effects of interferons, interleukin-1beta and tumor necrosis factor-alpha in normal (OSE) and malignant human ovarian epithelial cellsC Marth, A G Zeimet, M Herold, et al.Gynakologisch-Geburtshilfliche Rundschau|January 1, 1992
[Interferon-gamma suppresses expression of the HER-2 oncogene in ovarian cancer cells]C Marth, E Müller-Holzner, A G Zeimet, et al.Cytokine|July 6, 2000
Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cellsB Abendstein, S Stadlmann, C Knabbe, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
The prognostic value of nuclear roundness and neopterin in ovarian cancerC Marth, A Weger, E Müller-Holzner, et al.British Journal of Cancer|February 9, 2012
Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trialV Seebacher, S Polterauer, C Grimm, et al.Pageof 18